LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $500K | Hold |
1,533
| – | – | ﹤0.01% | 211 |
|
2025
Q1 | $371K | Hold |
1,533
| – | – | ﹤0.01% | 227 |
|
2024
Q4 | $424K | Sell |
1,533
-257
| -14% | -$71.1K | ﹤0.01% | 224 |
|
2024
Q3 | $526K | Sell |
1,790
-115
| -6% | -$33.8K | ﹤0.01% | 211 |
|
2024
Q2 | $476K | Hold |
1,905
| – | – | ﹤0.01% | 210 |
|
2024
Q1 | $278K | Hold |
1,905
| – | – | ﹤0.01% | 244 |
|
2023
Q4 | $329K | Hold |
1,905
| – | – | ﹤0.01% | 229 |
|
2023
Q3 | $308K | Sell |
1,905
-60
| -3% | -$9.69K | ﹤0.01% | 236 |
|
2023
Q2 | $373K | Hold |
1,965
| – | – | ﹤0.01% | 232 |
|
2023
Q1 | $394K | Hold |
1,965
| – | – | ﹤0.01% | 217 |
|
2022
Q4 | $467K | Hold |
1,965
| – | – | 0.01% | 199 |
|
2022
Q3 | $393K | Hold |
1,965
| – | – | 0.01% | 219 |
|
2022
Q2 | $287K | Sell |
1,965
-60
| -3% | -$8.76K | ﹤0.01% | 252 |
|
2022
Q1 | $331K | Hold |
2,025
| – | – | ﹤0.01% | 244 |
|
2021
Q4 | $343K | Hold |
2,025
| – | – | ﹤0.01% | 248 |
|
2021
Q3 | $382K | Sell |
2,025
-17
| -0.8% | -$3.21K | ﹤0.01% | 236 |
|
2021
Q2 | $346K | Sell |
2,042
-5
| -0.2% | -$847 | ﹤0.01% | 256 |
|
2021
Q1 | $289K | Buy |
2,047
+22
| +1% | +$3.11K | ﹤0.01% | 257 |
|
2020
Q4 | $263K | Hold |
2,025
| – | – | ﹤0.01% | 259 |
|
2020
Q3 | $295K | Hold |
2,025
| – | – | ﹤0.01% | 233 |
|
2020
Q2 | $300K | Hold |
2,025
| – | – | ﹤0.01% | 217 |
|
2020
Q1 | $220K | Hold |
2,025
| – | – | ﹤0.01% | 229 |
|
2019
Q4 | $233K | Hold |
2,025
| – | – | ﹤0.01% | 262 |
|
2019
Q3 | $163K | Hold |
2,025
| – | – | ﹤0.01% | 284 |
|
2019
Q2 | $147K | Hold |
2,025
| – | – | ﹤0.01% | 289 |
|
2019
Q1 | $189K | Hold |
2,025
| – | – | ﹤0.01% | 261 |
|
2018
Q4 | $148K | Sell |
2,025
-6,005
| -75% | -$439K | ﹤0.01% | 279 |
|
2018
Q3 | $703K | Hold |
8,030
| – | – | 0.01% | 182 |
|
2018
Q2 | $791K | Hold |
8,030
| – | – | 0.01% | 175 |
|
2018
Q1 | $956K | Hold |
8,030
| – | – | 0.02% | 164 |
|
2017
Q4 | $1.02M | Sell |
8,030
-245
| -3% | -$31.1K | 0.02% | 166 |
|
2017
Q3 | $972K | Hold |
8,275
| – | – | 0.02% | 161 |
|
2017
Q2 | $685K | Hold |
8,275
| – | – | 0.01% | 172 |
|
2017
Q1 | $424K | Hold |
8,275
| – | – | 0.01% | 200 |
|
2016
Q4 | $310K | Hold |
8,275
| – | – | 0.01% | 227 |
|
2016
Q3 | $561K | Sell |
8,275
-315
| -4% | -$21.4K | 0.01% | 184 |
|
2016
Q2 | $477K | Hold |
8,590
| – | – | 0.01% | 189 |
|
2016
Q1 | $539K | Hold |
8,590
| – | – | 0.01% | 180 |
|
2015
Q4 | $809K | Sell |
8,590
-4,215
| -33% | -$397K | 0.02% | 163 |
|
2015
Q3 | $1.54M | Hold |
12,805
| – | – | 0.04% | 127 |
|
2015
Q2 | $1.54M | Sell |
12,805
-2,305
| -15% | -$276K | 0.04% | 127 |
|
2015
Q1 | $1.58M | Sell |
15,110
-1,055
| -7% | -$110K | 0.04% | 127 |
|
2014
Q4 | $1.57M | Hold |
16,165
| – | – | 0.04% | 125 |
|
2014
Q3 | $1.26M | Hold |
16,165
| – | – | 0.03% | 133 |
|
2014
Q2 | $1.02M | Sell |
16,165
-150
| -0.9% | -$9.47K | 0.03% | 148 |
|
2014
Q1 | $1.1M | Sell |
16,315
-1,660
| -9% | -$111K | 0.03% | 145 |
|
2013
Q4 | $1.16M | Sell |
17,975
-3,375
| -16% | -$217K | 0.03% | 138 |
|
2013
Q3 | $1.37M | Sell |
21,350
-1,925
| -8% | -$123K | 0.04% | 126 |
|
2013
Q2 | $722K | Buy |
+23,275
| New | +$722K | 0.02% | 165 |
|